The common ALL BCR/ABL− patients exhibited a greater ability to generate new subpopulations, suggesting that the common ALL BCR/ABL− patients have exhibited more clonal evolution after induction therapy (Fig. 3). Here, BCR is linked to acute lymphoblastic leukemia.